Marché nord-américain du diagnostic des accidents vasculaires cérébraux – Tendances et prévisions du secteur jusqu’en 2028

Analyse et perspectives du marché : marché nord-américain du diagnostic des accidents vasculaires cérébraux

Le marché nord-américain du diagnostic des accidents vasculaires cérébraux devrait connaître une croissance au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché connaît une croissance de 6,6 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 2 097,75 millions USD d'ici 2028. La croissance de la R&D dans le secteur de la santé et l'augmentation des dépenses de santé sont les principaux moteurs qui devraient propulser la demande du marché au cours de la période de prévision. En revanche, les rappels de produits freinent le marché.

Un accident vasculaire cérébral survient lorsque l'apport sanguin au cerveau est diminué ou complètement bloqué, ce qui empêche le tissu cérébral de recevoir de l'oxygène et des nutriments. Différents types d'appareils de diagnostic sont utilisés pour détecter un accident vasculaire cérébral et ses premiers symptômes, par exemple la tomodensitométrie (TDM), l'angiographie par tomodensitométrie (CTA), l'imagerie par résonance magnétique (IRM), l'angiographie par résonance magnétique (ARM), l'échographie Doppler transcrânienne et d'autres.

L'incidence croissante des accidents vasculaires cérébraux et des maladies cardiovasculaires et neurologiques a accru la demande de diagnostics d'accidents vasculaires cérébraux dans les pays en développement. En outre, l'augmentation des dépenses de santé stimule la croissance du marché. D'un autre côté, le coût élevé du diagnostic peut freiner la croissance du marché. La présence d'acteurs sur le marché et le lancement de nouveaux produits offrent une opportunité. Cependant, le manque de professionnels qualifiés peut constituer un défi pour le marché.

Le rapport sur le marché du diagnostic des accidents vasculaires cérébraux fournit des détails sur la part de marché, les nouveaux développements, l'impact des acteurs du marché national et local, l'analyse des opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits , les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste. Notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Portée et taille du marché du diagnostic des accidents vasculaires cérébraux en Amérique du Nord

The North America stroke diagnostics market is segmented on the basis of severity, type, application, end user, distribution channel, and stage. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of severity, the North America stroke diagnostics market is segmented into moderate, severe, and mild. In 2021, the moderate segment is expected to dominate the market, with a surge in the increasing R&D activities.
• On the basis of type, the North America stroke diagnostics market is segmented into computed tomography (CT Scan), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, video head impulse test (VHIT), other. In 2021, the computed tomography (CT scan) segment is expected to dominate the market with the increasing government initiatives to provide better-advanced devices.
• On the basis of application, the North America stroke diagnostics market is segmented into ischemic stroke, hemorrhagic stroke, and transient ischemic attacks (TIAS). In 2021, ischemic stroke is expected to dominate the market with the increasing product launch by major market players.
• On the basis of end-users, the North America stroke diagnostics market is segmented into hospitals, home healthcare, ambulatory surgical centers, and clinics. In 2021, the hospital segment is expected to dominate the market with the presence of skilled professionals and staff.
• On the basis of distribution channel, the North America stroke diagnostics market is segmented into direct tender, third party distributor, and others. In 2021, direct tender is expected to dominate the market due to the growing number of patients with stroke.
• On the basis of stage, the North America stroke diagnostics market is segmented into pre-operative, peri-operative, and post-operative. In 2021, pre-operative is expected to dominate the market due to the increasing advancement in product development.

Stroke Diagnostics Market Country Level Analysis

The stroke diagnostics market is analyzed, and market size information is provided on the basis of severity, type, application, end users, distribution channel, and stage.

The countries covered in the North America stroke diagnostics market report are the U.S., Canada, and Mexico.

The stroke diagnostics segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing research development for enhancing the product quality. The U.S is expected to lead the growth of the North America stroke diagnostics market, and the direct tender segment is anticipated to dominate due to the rising incidence of disease in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Increase in Advancement and Technology for New Product Development is Boosting the Market Growth of Stroke diagnostics

The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the stroke diagnostics industry with stroke diagnostics drugs sales, the impact of advancement in the stroke diagnostics technology, and changes in regulatory scenarios with their support for the stroke diagnostics market. The data is available for the historic period 2011 to 2019.

Competitive Landscape and Stroke Diagnostics Market Share Analysis

Stroke diagnostics market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.

The major companies which are dealing in the North America stroke diagnostics market are Siemens, Koninklijke Philips N.V., Stryker, Hologic, Inc., ESAOTE SPA, Medtron AG, Shenzhen Anke High-Tech CO., Ltd, Aspect Imaging Ltd, Siemens, FONAR Corp, FUJIFILM Holdings Corporation, General Electric Company, ALPINION MEDICAL SYSTEMS Co., Ltd., Ltd, TERASON DIVISION TERATECH CORPORATION, Analogic Corporation, Carestream Health, IMRIS, Deerfield Imaging Inc., Canon Inc., SAMSUNG, SternMed GmbH among others.

Many product launches and agreements are also initiated by companies worldwide, which also accelerates the stroke diagnostics market.

For instance,

• In February 2021, Koninklijke Philips N.V  announced that they had successfully completed the acquisition of BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. The acquisition has added the new technological wearable sensing products to their product pipeline
• In September 2021, SAMSUNG announced that they had completed the acquisition of the company in HARMAN. The acquisition has increased the company's product portfolio and technological advancement

La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché améliorent le marché de l'entreprise sur le marché du diagnostic des accidents vasculaires cérébraux, ce qui offre également à l'organisation l'avantage d'améliorer son offre de diagnostic des accidents vasculaires cérébraux.

SKU-66145